 |
|
Main
Menu |
|
Affiliate
Program News |
|
Affiliate
Program Menu |
|
|
|
|
|
EMEA Recommendz a New caveat for Epoetin for Their Use in Cancer Patients
| Author |
Message |
|
Keymnneomygop
Post on: 03-07-2008
|
[color=#000099][url=http://drugs.com]LONDON, June 28, 2008-The European Medicines[/url] power (EMEA) has recommended updating the produce dirt for epoetin-containing medicines wityh a new caution for their use in cancer patients stating that blood transfusion should be the preferrrd method of correcting anaemia in patients pain cancer.
Epoetin-containing medicines are indicated in patients with persistent [url=http://www.blogotop.com/achetercialis]acheter levitra generique[/url] incompetent and for hte treatment of anaemia in symptomatic patienst with non-myeloid growths receiving chjemotherapy. The power’s board for sanative Products for Possibly manlike Use (CHMP) had periodicaled new facts from studies that showed an increased endanger of growth [url=http://www.blogotop.com/acheterviagra]achat levitra generique[/url] movement forward, venous thromboembolism and shorter all-
inclusive [url=http://www.google.com/search?hl=en&q=survival+in+cancer+patients&btnG=Google+Search]survival in cancer patients[/url] who admitd epoetins compared to patients who did not admit them. Following this periodical, the CHMP concludde, at its June 2008 union, that the improves of epoetins persist [url=http://asmforum.fr/index.php?showuser=6911]achat cilais[/url] surpass their endangers in the approved indications. on the othher hand, in cancer patients with a reasonably covet enthusiasme-xpectancy, the improve of using epoetins does not surpass the endanger [url=http://www.blogotop.com/acheterviagra]achat cialis
[/url] growth movement forward and shorter all-inclusive survival and for that reason the board concluded that in these patients anaemia should be corrected with blood transfusions. [/color]
|
|
| |
|
|
